DLBCL | diffuse large B cell lymphoma |
TCRβ | β-peptide variable region of T cell receptor |
CAR | chimeric antigen receptor |
4-1BB | CD137 co-stimulatory domain |
CRS | cytokine release syndrome |
PD-1 | programmed cell death protein 1 |
Tim-3 | T cell immunoglobulin mucin domain 3 |
LAG-3 | lymphocyte activation gene 3 protein |
IND | investigational new drug |
PCR | polymerase chain reaction |
PBMCs | peripheral blood mononuclear cells |
HS | hemophagocytic syndrome |